1. Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice. Issue 2 (9th August 2016) Authors: Peferoen, Laura A. N.; Breur, Marjolein; van de Berg, Sarah; Peferoen‐Baert, Regina; Boddeke, Erik H. W. G. M.; van der Valk, Paul; Pryce, Gareth; van Noort, Johannes M.; Baker, David; Amor, Sandra Journal: Immunology Issue: Volume 149:Issue 2(2016) Page Start: 146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Alemtuzumab depletion failure can occur in multiple sclerosis. Issue 2 (4th January 2018) Authors: Dubuisson, Nicolas; Baker, David; Kang, Angray S.; Pryce, Gareth; Marta, Monica; Visser, Leo H.; Hofmann, Werner E.; Gnanapavan, Sharmilee; Giovannoni, Gavin; Schmierer, Klaus Journal: Immunology Issue: Volume 154:Issue 2(2018) Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antidote to cannabinoid intoxication: the CB1 receptor inverse agonist, AM251, reverses hypothermic effects of the CB1 receptor agonist, CB‐13, in mice. (20th September 2017) Authors: Pryce, Gareth; Baker, David Journal: British journal of pharmacology Issue: Volume 174:Number 21(2017) Page Start: 3790 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosis. Issue 1 (7th October 2022) Authors: Licht‐Mayer, Simon; Campbell, Graham R.; Mehta, Arpan R.; McGill, Katie; Symonds, Alex; Al‐Azki, Sarah; Pryce, Gareth; Zandee, Stephanie; Zhao, Chao; Kipp, Markus; Smith, Kenneth J.; Baker, David; Altmann, Daniel; Anderton, Stephen M.; Kap, Yolanda S.; Laman, Jon D.; 't Hart, Bert A.; Rodriguez, ... Journal: Neuropathology & applied neurobiology Issue: Volume 49:Issue 1(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Big conductance calcium‐activated potassium channel openers control spasticity without sedation. (7th July 2017) Authors: Baker, David; Pryce, Gareth; Visintin, Cristina; Sisay, Sofia; Bondarenko, Alexander I; Vanessa Ho, W S; Jackson, Samuel J; Williams, Thomas E; Al‐Izki, Sarah; Sevastou, Ioanna; Okuyama, Masahiro; Graier, Wolfgang F; Stevenson, Lesley A; Tanner, Carolyn; Ross, Ruth; Pertwee, Roger G; Henstridge, ... Journal: British journal of pharmacology Issue: Volume 174:Number 16(2017) Page Start: 2662 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Brain Endothelial miR-146a Negatively Modulates T-Cell Adhesion through Repressing Multiple Targets to Inhibit NF-κB Activation. Issue 3 (March 2015) Authors: Wu, Dongsheng; Cerutti, Camilla; Lopez-Ramirez, Miguel A; Pryce, Gareth; King-Robson, Josh; Simpson, Julie E; van der Pol, Susanne MA; Hirst, Mark C; de Vries, Helga E; Sharrack, Basil; Baker, David; Male, David K; Michael, Gregory J; Romero, Ignacio A Journal: Journal of cerebral blood flow & metabolism Issue: Volume 35:Issue 3(2015) Page Start: 412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cannabinoids fail to show evidence of slowing down the progression of multiple sclerosis. Issue 4 (20th April 2015) Authors: Pryce, Gareth; Baker, David Journal: Evidence-based medicine Issue: Volume 20:Issue 4(2015) Page Start: 124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Control of spasticity in a multiple sclerosis model using central nervous system‐excluded CB1 cannabinoid receptor agonists. Issue 1 (11th October 2013) Authors: Pryce, Gareth; Visintin, Cristina; Ramagopalan, Sreeram V.; Al‐Izki, Sarah; De Faveri, Lia E.; Nuamah, Rosamond A.; Mein, Charles A.; Montpetit, Alexandre; Hardcastle, Alison J.; Kooij, Gijs; de Vries, Helga E.; Amor, Sandra; Thomas, Sarah A.; Ledent, Catherine; Marsicano, Giovanni; Lutz, Beat; T... Journal: FASEB journal Issue: Volume 28:Issue 1(2014) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Depletion of CD52‐positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune‐tolerance promoting CD8 T‐cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis. Issue 4 (3rd January 2017) Authors: von Kutzleben, Stephanie; Pryce, Gareth; Giovannoni, Gavin; Baker, David Journal: Immunology Issue: Volume 150:Issue 4(2017) Page Start: 444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Detecting and predicting neutralization of alemtuzumab responses in MS. Issue 4 (July 2020) Authors: Saxena, Gauri; Moore, James M.; Jones, Meleri; Pryce, Gareth; Ali, Liaqat; Leisegang, Georgia R.; Vijay, Vivek; Loveless, Samantha; Robertson, Neil P.; Schmierer, Klaus; Giovannoni, Gavin; Gnananpavan, Sharmilee; Baker, David; Tallantyre, Emma C.; Kang, Angray S. Journal: Neurology Issue: Volume 7:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗